Gujarat Kidney & Super Speciality IPO Opens Today

The much-awaited Gujarat Kidney & Super Speciality (GKSS) IPO opened for subscription on December 22, 2025. The company has set the price band at Rs 108-114 per share, and investors have until December 24, 2025 to apply.

GKSS is a leading healthcare provider in Gujarat, specializing in nephrology, dialysis, and super speciality treatments. The IPO aims to raise funds to expand hospital infrastructure, upgrade medical technology, and reduce debt.

1. Issue Price & Size

The IPO price has been fixed in the band of Rs 108-114 per equity share. Based on the issue size, GKSS is expected to mobilize significant capital for business growth and healthcare expansion. Investors should carefully review the final issue price before placing bids.

2. Grey Market Premium (GMP)

The GMP for GKSS IPO has shown positive momentum in the days leading up to the listing. Grey Market activity indicates investor enthusiasm and potential listing gains. However, GMP is indicative only and not guaranteed, so investors should consider it along with fundamentals.

3. Subscription & Lot Size

• IPO subscription dates: December 22–24, 2025

• Lot size: Minimum of 130 shares per application

• Investors can apply through ASBA (Application Supported by Blocked Amount) or through their broker’s platform.

4. Company Overview

Gujarat Kidney & Super Speciality runs a network of advanced hospitals and dialysis centers across Gujarat. It has been recognized for:

• Comprehensive kidney care and dialysis services

• Super speciality treatments including cardiology, oncology, and critical care

• Advanced medical equipment and patient-centric services

• Strong regional brand presence in healthcare services

Funds raised through the IPO will help the company expand existing facilities, set up new centers, and strengthen operational capabilities.

5. Potential Investor Gains

Investors looking at the GKSS IPO should consider:

• Short-term listing gains based on GMP trends

• Long-term value due to expansion in Gujarat’s healthcare sector

• Rising demand for dialysis and super speciality care in tier-2 and tier-3 cities

• Experienced management team with a proven track record

Conclusion

The Gujarat Kidney & Super Speciality IPO offers investors a chance to participate in a growing healthcare network in Gujarat. With the subscription open till December 24, 2025, interested investors should evaluate the issue price, GMP, and growth potential before applying. The IPO represents both short-term listing opportunities and long-term healthcare investment prospects.

Join our Telegram Channel for Latest News and Regular Updates.

Start your Mutual Fund Journey  by Opening Free Account in Asset Plus.

Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.